Pathophysiology of the inflammatory response

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 4 I, 1999, Pages

  Pearlman, David S ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b Respiratory Institute   (United States)

Author keywords

Allergic rhinitis; Allergy; Asthma; Atopy; Interleukins; Mast cells

Indexed keywords

CHEMOATTRACTANT; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 4;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; B LYMPHOCYTE; CYTOKINE RELEASE; HYPERSENSITIVITY; IMMUNE RESPONSE; INFLAMMATION; MAST CELL; MEDIATOR RELEASE; MEMORY CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0033501912     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(99)70308-8     Document Type: Article

References (41)

1. Lang DM. Trends in US asthma mortality: good news and bad news. Ann Allergy Asthma Immunol 1997;78:333-7.
2. Ledford DK, Lockey RE Allergic rhinitis: offering relief this season. J Respir Dis 1998;19:647-66.
3. Naclerio R, Solomon W. Rhinitis and inhalant allergens. JAMA 1997;278:1842-8.
4. Leung DYM. Molecular basis of allergic diseases. Mol Genet Metab 1998;63:157-67.
5. Fokkens WJ, Broekhuis-Fluitsma DM, Rijntjes E, Vroom TN, Hoefsmit ECM. Langerhans cells in nasal mucosa of patients with grass pollen allergy. Immunobiology 1991;182:135-42.
6. Busse WW, Coffman RL, Gelfand EW, Kay AB, Rosenwasser LJ. Mechanisms of persistent airway inflammation in asthma: a role for T cells and T-cell products. Am J Respir Crit Care Med 1995;152:388-93.
7. Calderón MA, Lozewicz S, Prior A, Jordan S, Trigg CJ, Davies RJ. Lymphocyte infiltration and thickness of the nasal mucous membrane in perennial and seasonal allergic rhinitis. J Allergy Clin Immunol 1994;93:635-43.
8. H2 cells. J Immunol 1992;148:3820-9.
9. Romagnani S. Biology of human TH1 and TH2 cells. J Clin Immunol 1995;15:121-9.
10. Borish L, Rosenwasser LJ. Update on cytokines. J Allergy Clin Immunol 1996;97:719-34.
11. Bachert C, Prohaska P, Pipkorn U. IgE-positive mast cells on the human nasal mucosal surface in response to allergen exposure. Rhinology 1990;28:149-58.
12. Chang TW, Davis FM, Sun N-C, Sun CRY, MacGlashan DW Jr, Hamilton RG. Monoclonal antibodies specific for human IgE-producing B cells: a potential therapeutic for IgE-mediated allergic diseases. Biotechnology 1990;8:122-6.
13. MacGlashan DW Jr, Bochner BS, Adelman DC, Jardieu PM, Togias A, MacKensie-White J, et al. Down-regulation of FceRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 1997;158:1438-45.
14. Tunon-De-Lara JM, Redington AE, Bradding P, Church MK, Hartley JA, Semper AE, et al. Dendritic cells in normal and asthmatic airways: expression of the α subunit of the high affinity immunoglobulin E receptor (FceRI-α). Clin Exp Allergy 1996;26:648-55.
15. Baraniuk JN. Pathogenesis of allergic rhinitis. J Allergy Clin Immunol 1997;99:S763-72.
16. Juliusson S, Aldenborg F, Enerbäck L. Proteinease content of mast cells of nasal mucosa: effects of natural allergen exposure and of local corticosteroid treatment. Allergy 1995;50:15-22.
17. Kawabori Y, Kanai N, Tosho T. Proliferative activity of mast cells in allergic nasal mucosa. Clin Exp Allergy 1995;25:173-8.
18. 1 receptorin human nasal turbinates. J Allergy Clin Immunol 1992;89:1144-50.
19. Spector SL. Leukotriene inhibitors and antagonists in asthma. Ann Allergy Asthma Immunol 1995;75:463-74.
20. Pober JS, Lapierre LA, Stolpen AH, Brock TA, Springer TA, Fiers W, et al. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. J Immunol 1987;138:3319-24.
21. Mosimann BL, White MV, Hohman RJ, Goldrich MS, Kaulbach HC, Kaliner MA. Substance P, calcitonin-gene related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J Allergy Clin Immunol 1993;92:95-104.
22. Fajac I, Braunstein G, Ickovic MR, Lacromique J, Frossard N. Selective recruitment of eosinophils by substance P after repeated allergen exposure in allergic rhinitis. Allergy 1995;50:970-5.
23. Okamoto Y, Shirotori K, Kudo K, Ishikawa K, Ito E, Togawa K, et al. Cytokine expression after the topical administration of substance P to human nasal mucosa: the role of substance P in nasal allergy. J Immunol 1993;151:4391-8.
24. Kaufman J, Chen JC, Wright GW. The effect of trigeminal resection in reflex bronchoconstriction after nasal and nasopharyngeal irritation in man. Am Rev Respir Dis 1970;101:768-9.
25. 3 muscarinic antagonists inhibit human nasal glandular secretion in vitro. J Appl Physiol 1992;73:2069-73.
26. Horwitz RJ, Busse WW. Inflammation and asthma. Clin Chest Med 1995;16:583-602.
27. Bascom R, Wachs M, Naclerio RM, Pipkorn U, Galli SJ, Lichtenstein LM. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988;81:580-9.
28. Bochner BS, Schleimer RP. The role of adhesion molecules in human eosinophil and basophil recruitment. J Allergy Clin Immunol 1994;94:427-38.
29. Lee B-J, Naclerio RM, Bochner BS, Taylor RM, Lim MC, Baroody FM. Nasal challenge with allergen upregulates the local expression of vascular endothelial adhesion molecules. J Allergy Clin Immunol 1994;94:1006-16.
30. Montefort S, Feather IH, Wilson SJ, Haskard DO, Lee TH, Holgate ST, et al. The expression of leukocyte-endothelial adhesion molecules is increased in perennial allergic rhinitis. Am J Respir Cell Mol Biol 1992;7:393-8.
31. Terada N, Konno A, Togawa K. Biochemical properties of eosinophils and their preferential accumulation mechanism in nasal allergy. J Allergy Clin Immunol 1994;94:629-42.
32. Nakajima H, Sano H, Nishimura T, Yoshida S, Iwamoto I. Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J Exp Med 1994;179:1145-54.
33. Moqbel R, Levi-Schaffer F, Kay AB. Cytokine generation by eosinophils. J Allergy Clin Immunol 1994;94:1183-8.
34. Druce HM, Wright RH, Kossoff D, Kaliner MA. Cholinergic nasal hyperreactivity in atopic subjects. J Allergy Clin Immunol 1985;76:445-52.
35. Akutsu I, Kojima T, Kariyone A, Fukuda T, Makino S, Takatsu K. Antibody against interleukin-5 prevents antigen-induced eosinophil infiltration and bronchial hyperreactivity in the guinea pig airways. Immunol Lett 1995;45:109-16.
36. Kung TT, Stelts DM, Zurcher JA, Adams GK III, Egan RW, Kreutner W, et al. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and therapeutic effect of an anti-IL-5 antibody. Am J Respir Cell Mol Biol 1995;13:360-5.
37. Mauser PJ, Pitman AM, Fernandez X, Forau SK, Adams GK III, Kreutner W, et al. Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med 1995;152:467-72.
38. Pawankar RU, Okuda M, Okubo K, Ra C. Lymphocyte subsets in the nasal mucosa in perennial allergic rhinitis. Am J Respir Crit Care Med 1995;152:2049-58.
39. Kuna P, Lazarovich M, Kaplan AP. Chemokines in seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97:104-12.
40. Nonaka M, Nonaka R, Jordana M, Dolovich J. GM-CSF, IL-8, IL-1R, TNF-aR, and HLA-DR in nasal epithelial cells in allergic rhinitis. Am J Respir Crit Care Med 1996;153:1675-81.
41. Devalia JL, Campbell AM, Sapsford RJ, Ruszna KC, Quint D, Godard P, et al. Effect of nitrogen dioxide on synthesis of inflammatory cytokines expressed by human bronchial epithelial cells in vitro. Am J Respir Cell Mol Biol 1993;9:271-8.